Related Experiment Video
Updated: Oct 17, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants
Abie Rohrig1,2, Nir Eyal3
11Day Sooner, New York, USA.
Abstract:
The world's first coronavirus disease 2019 human challenge trial using the D614G strain of severe acute respiratory syndrome 2 (SARS-CoV-2) is underway in the United Kingdom. The Wellcome Trust is funding challenge stock preparation of the Beta and Delta variant for a follow-up human challenge trial, and researchers at hVIVO are considering conducting these trials. However, little has been written thus far about the ethical justifiability of human challenge trials with SARS-CoV-2 variants of concern. We explore 2 specific characteristics of some variants that may initially be thought to make such trials unethical and conclude that SARS-CoV-2 variant challenge trials can remain ethical.
Insights
Ethical considerations for human challenge trials involving severe acute respiratory syndrome 2 (SARS-CoV-2) variants are explored. The study concludes that such trials, even with concerning variants, can be ethically justified.
Area of Science:
- Infectious Diseases
- Bioethics
- Virology
Background:
- The first coronavirus disease 2019 (COVID-19) human challenge trial utilized the D614G strain of severe acute respiratory syndrome 2 (SARS-CoV-2).
- Preparation for follow-up trials using Beta and Delta variants is funded, with researchers considering their execution.
Purpose of the Study:
- To examine the ethical justifiability of human challenge trials involving SARS-CoV-2 variants of concern.
- To address specific variant characteristics that might raise ethical concerns.
Main Methods:
- Literature review and ethical analysis of human challenge trial protocols.
- Exploration of specific characteristics of SARS-CoV-2 variants relevant to ethical considerations.
Main Results:
- Existing literature on the ethics of SARS-CoV-2 variant challenge trials is limited.
- Two specific variant characteristics, initially perceived as ethically problematic, are analyzed.
Conclusions:
- SARS-CoV-2 variant challenge trials can be conducted ethically.
- Ethical frameworks can accommodate the challenges posed by variants of concern in human challenge trials.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
07:48Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
Published on: May 16, 2016
Related Concept Videos
Ethics in Research
Ethical Dilemmas II
Ethical Issues
Ethical Concerns in Healthcare:
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Ethical Dilemmas I
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Ethical Standards II
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...